In light of these unanswered questions, the aim of the current study was to investigate the temporal and spatial relationship between changes of CAMs and KLF4 and BBB dysfunction and uncover the molecular mechanisms of KLF4 in protecting against vascular injury following CIS. This evidence concerns the gene KLF4 and in situ carcinoma.